touchImmunology Future Leader 2026

We're proud to share that our co-founder and CEO, Cedric Bogaert, has been named a touchIMMUNOLOGY Future Leader 2026 - selected by peers as one of the immunologists changing the future of precision medicine.

This recognition reflects not just Cedric's vision, but the work of the entire myNEO team over the past seven years - advancing antigen discovery, building partnerships with leading biopharma companies, and seeing the first patients treated with immunogenic tumor targets identified through our platform.

We're proud of how far we've come, and excited for what's ahead.

🔗 Read the full feature via the link: https://touchimmunology.com/insight/cedric-bogaert-on-the-intersection-of-precision-diagnostics-and-immunotherapy-touchimmunology-future-leaders-2026/